ROMEO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 46.312
AS - Asia 4.965
EU - Europa 4.647
SA - Sud America 792
Continente sconosciuto - Info sul continente non disponibili 436
AF - Africa 95
OC - Oceania 38
Totale 57.285
Nazione #
US - Stati Uniti d'America 46.037
SG - Singapore 2.232
CN - Cina 1.007
IT - Italia 781
BR - Brasile 652
DE - Germania 633
RU - Federazione Russa 604
UA - Ucraina 544
VN - Vietnam 449
HK - Hong Kong 412
IE - Irlanda 407
FR - Francia 341
PL - Polonia 286
GB - Regno Unito 264
SE - Svezia 263
FI - Finlandia 230
BD - Bangladesh 201
CA - Canada 144
JP - Giappone 138
KR - Corea 113
IN - India 97
NL - Olanda 57
ES - Italia 53
ID - Indonesia 52
AR - Argentina 47
TR - Turchia 45
BE - Belgio 42
MX - Messico 39
ZA - Sudafrica 38
AT - Austria 36
IR - Iran 32
IQ - Iraq 31
AU - Australia 30
EC - Ecuador 23
IL - Israele 23
MA - Marocco 21
CO - Colombia 19
PH - Filippine 19
VE - Venezuela 17
CL - Cile 16
CZ - Repubblica Ceca 16
PK - Pakistan 16
RO - Romania 15
AE - Emirati Arabi Uniti 14
CR - Costa Rica 14
HN - Honduras 12
LT - Lituania 12
PT - Portogallo 11
JM - Giamaica 10
MY - Malesia 10
SA - Arabia Saudita 9
CW - ???statistics.table.value.countryCode.CW??? 8
EG - Egitto 8
GT - Guatemala 8
GR - Grecia 7
KE - Kenya 7
KZ - Kazakistan 7
NZ - Nuova Zelanda 7
PY - Paraguay 7
SV - El Salvador 7
TH - Thailandia 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
DK - Danimarca 6
EU - Europa 6
GP - Guadalupe 6
HU - Ungheria 6
PE - Perù 6
PR - Porto Rico 6
TN - Tunisia 6
UZ - Uzbekistan 6
BG - Bulgaria 5
CH - Svizzera 5
DZ - Algeria 5
KG - Kirghizistan 5
NI - Nicaragua 5
NP - Nepal 5
PA - Panama 5
RS - Serbia 5
SC - Seychelles 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
EE - Estonia 4
JO - Giordania 4
AL - Albania 3
BO - Bolivia 3
LB - Libano 3
MD - Moldavia 3
OM - Oman 3
BB - Barbados 2
BM - Bermuda 2
CY - Cipro 2
GD - Grenada 2
KW - Kuwait 2
LU - Lussemburgo 2
MK - Macedonia 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
Totale 56.849
Città #
Woodbridge 12.394
Houston 10.486
Wilmington 10.483
Fairfield 1.316
Singapore 1.244
Ashburn 1.211
Chandler 952
Ann Arbor 908
San Jose 699
Seattle 583
Jacksonville 472
Beijing 455
Cambridge 435
Hong Kong 405
Dublin 381
Dearborn 342
Council Bluffs 297
New York 296
Medford 279
Kraków 254
Rome 245
Santa Clara 228
Los Angeles 216
The Dalles 186
Ho Chi Minh City 137
Lawrence 129
Tokyo 108
Hanoi 105
Helsinki 99
Buffalo 95
Moscow 91
Chicago 86
São Paulo 84
Dallas 79
Lauterbourg 76
Milan 75
San Diego 70
Menlo Park 68
Mülheim 60
North Bergen 54
Orem 54
Boardman 53
London 49
Brussels 42
Denver 42
Phoenix 39
Atlanta 37
Toronto 35
Norwalk 32
Nuremberg 32
Palo Alto 32
Guangzhou 31
Jakarta 31
Brooklyn 30
Montreal 30
Munich 30
Redwood City 28
Verona 28
Johannesburg 27
Warsaw 27
Redondo Beach 25
Mountain View 24
Stockholm 24
Hefei 23
Chennai 22
Frankfurt am Main 22
Hangzhou 22
San Francisco 22
Washington 22
Haiphong 21
Da Nang 20
Elk Grove Village 20
Falls Church 19
Naples 19
Salt Lake City 19
University Park 19
Columbus 18
Amsterdam 17
Madrid 17
Manchester 17
Nanjing 17
Dong Ket 15
Durham 15
Kunming 15
Poplar 15
Rio de Janeiro 15
Newark 14
Philadelphia 14
Shanghai 14
Ankara 13
Brno 13
Charlotte 13
Curitiba 13
Detroit 13
Las Vegas 13
Saint Augustine 13
Saint Petersburg 13
Zhengzhou 13
Belo Horizonte 12
Creede 12
Totale 47.579
Nome #
Acute left hemothorax as a late complication of an active-fixation pacemaker lead. 890
Multislice computed tomography in an asymptomatic high-risk population 677
Mutational Analysis of Mitochondrial DNA in Brugada Syndrome 605
Percutaneous transfemoral-transseptal implantation of a second-generation CardiAQ™ mitral valve bioprosthesis: first procedure description and 30-day follow-up 592
A score including ADAM17 substrates correlates to recurring cardiovascular event in subjects with atherosclerosis 579
Cardiovascular medicine heart failure (CVM-HF) index as prognostic model for candidates to MitraClip therapy 567
Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy 539
Unsedated transnasal versus transoral sedated upper gastrointestinal endoscopy: a one-series prospective study on safety and patient acceptability 529
GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation 523
Accuracy of thin-slice computed tomography in the detection of coronary stenoses 520
Transcatheter aortic valve implantation through distal axillary artery: novel option for vascular access 515
Population differences in allele frequencies at the OLR1 locus may suggest geographic disparities in cardiovascular risk events. 512
Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy 505
Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity. 502
Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol 500
The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients 499
Decreased plasma adiponectin concentration in major depression 498
The protective effect of superoxide dismutase mimetic M40401 on balloon injury-related neointima formation: Role of the lectin-like oxidized low-density lipoprotein receptor-1 498
Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: the INtegrilin plus STenting to Avoid myocardial Necrosis Trial 495
Local immune activity in acute coronary syndrome: oxLDL abrogates LPS-tolerance in mononuclear cells isolated from culprit lesion 494
A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial 492
A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial 492
Successful Coronary Stent Retrieval From a Pedal Artery 492
Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. 491
Combined pulmonary fibrosis and emphysema: 3D time-resolved MR angiographic evaluation of pulmonary arterial mean transit time and time to peak enhancement 489
Functional assessment of the collateral-dependent circulation in chronic total coronary occlusion using transthoracic Doppler ultrasound and venous adenosine infusion 489
Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: early results of a prospective multicenter study 487
Atherosclerosis severity but not undiagnosed diabetes predicts new cardiovascular events of subjects in secondary cardiovascular prevention. 484
Role of 64-slice cardiac computed tomography in the evaluation of patients with non-ST-elevation acute coronary syndrome 482
Thrombolysis in ST-segment elevation myocardial infarction: potential role of thin-slice computed tomography in the assessment of reperfusion and plaque characterization 482
LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet 481
An increased endothelial-independent vasodilation is the hallmark of the neurally mediated syncope 479
The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: A comprehensive meta-analysis 475
First clinical experience with the new four-pole standard connector for high-voltage ICD leads. Early results of a multicenter comparison with conventional implant outcomes 475
Clinical results with the 31 mm CoreValve™ in large aortic annuli: The importance of implantation technique 474
Transcatheter occlusion of left atrial appendage with persistent thrombus using a trans-radial embolic protection device 471
Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1 470
Coronary flow reserve of the angiographically normal left anterior descending coronary artery in patients with remote coronary artery disease 469
Evaluation of coronary in-stent restenosis by 64-slice computed tomography in patients with optimal heart rate control by systematic administration of beta-blocker drugs. 468
Evaluation of venous and arterial conduit patency by 16-slice spiral computed tomography 467
Hemodynamic patterns of residual interatrial communication after transcatheter MitraClip repair 467
Dexamethasone inhibits the inducible bioconversion of glyceryl trinitrate to nitric oxide 467
Impact of pre-existent areas of complex fractionated atrial electrograms on outcome after pulmonary vein isolation 466
Transcatheter closure of paravalvular leak secondary to left ventricular peri-annular pseudoaneurysm 465
Role of genetics in prevention of coronary atherosclerosis 462
Percutaneous closure of patent foramen ovale with Atriasept II device in nickel allergic patients 460
A novel methodology for AV and VV delay optimization in CRT: results from a randomized pilot clinical trial 459
Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD 458
Chronic obstructive pulmonary disease and coronary disease: COPDCoRi, a simple and effective algorithm for predicting the risk of coronary artery disease in COPD patients 457
Lack of intra-aortic balloon pump effectiveness in high-risk percutaneous coronary interventions without cardiogenic shock: A comprehensive meta-analysis of randomised trials and observational studies 457
Correlations between personality factors and coronary artery disease: From type A behaviour pattern to type D personality 457
Association between OLR1 K167N SNP and Intima Media Thickness of the Common Carotid Artery in the General Population. 456
Short-Term and Two-Year Rate of Recurrent Cerebrovascular Events in Patients with Acute Cerebral Ischemia of Undetermined Aetiology, with and without a Patent Foramen Ovale 456
Revascularization strategy in patients with multivessel disease and a major vessel chronically occluded; data from the CABRI trial 455
Decreased plasma adiponectin concentration in major depression 455
Reduction of left ventricular hypertrophy detected by cardiac magnetic resonance in a patient after renal denervation 455
Occult impaired glucose regulation in patients with atherosclerosis is associated to the number of affected vascular districts and inflammation 450
Cardiovascular disease in asthma and COPD: A population-based retrospective cross-sectional study 450
LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy. 450
Safety and efficacy of a new magnetic resonance imaging-compatible pacing system: early results of a prospective comparison with conventional dual-chamber implant outcomes 449
Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol 449
Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. 448
Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system 444
Trial sequential analysis: The role of the number needed-to-treat in evaluating the clinical relevance of relative risk reduction values in the intra-aortic balloon pump support 442
Pharmacogenetics in cardiovascular disorders: an update on the principal drugs 441
Screening of asymptomatic rheumatic heart disease among refugee/migrant children and youths in Italy 438
Images in cardiology: Thrombolysis in ST-segment elevation myocardial infarction: Potential role of thin-slice computed tomography in the assessment of reperfusion and plaque characterization 437
Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy 437
Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study 437
Role of genomics in cardiovascular medicine 436
Impact of continuous intracardiac ST-segment monitoring on mid-term outcomes of ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes 435
A clinical score to predict the need for intraaortic balloon pump in patients undergoing coronary artery bypass grafting 434
In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction 433
Use of a comprehensive numerical model to improve biventricular pacemaker temporization in patients affected by heart failure undergoing to CRT-D therapy 433
Mechanical Circulatory Support and Rationale for Future Research 433
Clinical and electrical performance of currently available MRI-safe pacing systems. Do all devices perform in the same way? 431
Cardiac resynchronization therapy before and after MitraClip implantation: An advantageous upgrading to reduce mitral regurgitation 431
Cardiovascular disease in asthma and COPD: a population-based retrospective cross-sectional study 429
Beyond the cardiovascular risk charts: The new way of hybrid profiles 428
Non-invasive hemodynamic analysis in cardiac resynchronization therapy patients wearing quadripolar left ventricular leads: the importance of pacing electrode selection 427
Hospitalization rates and associated cost analysis of cardiac resynchronization therapy with an implantable defibrillator and quadripolar vs. bipolar left ventricular leads: a comparative effectiveness study 425
Trans-catheter mitral valve implantation for mitral regurgitation: clinical case description and literature review. 425
Endothelial dysfunction is a marker of systemic response to the cardiac resynchronization therapy in heart failure 425
New insights in atherosclerosis research: LOX-1, leading actor of cardiovascular diseases [Nuovi approfondimenti nella ricerca su l'ateroslerosi: LOX-1, un primo attore nelle malattie cardiovascolari] 423
Cardiac MRI with SENSE technology: Study of ventricular and valvular functionality in 30 patients = Cardio-RM con tecnologia SENSE: studio della funzionalità ventricolare e valvolare in 30 pazienti 422
Large coronary aneurysm following laser angioplasty of the left anterior descending coronary artery 422
Cryptogenic cerebral ischemia: clinical usefulness of a flexible ultrasound diagnostic algorithm for detection of patent foramen ovale 417
Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection 416
Early detection of high voltage lead failure with an unusual and unexpected device alert 415
Genotyping OLR1 gene: A genomic biomarker for cardiovascular diseases 413
Unexplained syncope in a patient with Brugada-like electrocardiogram. Lighting the dark side of underlying bradyarrhythmias 411
[Diabetes worsens the clinical manifestations and prognosis of concurrent cardiovascular and kidney disease] 410
Further evidence that polymorphisms of the OLR1 gene are associated with susceptibility to coronary artery disease and myocardial infarction 409
Prevalence and significance of Brugada-type ECG in 12,012 apparently healthy European subjects 408
Optimal duration of dual anti-platelet therapy after percutaneous coronary intervention: 2016 consensus position of the Italian Society of Cardiology 408
OLR1 gene and coronary artery disease/acute myocardial infarction: Replication in an independently collected sample [1] 405
Inhibition of LOX-1 by statins may relate to upregulation of eNOS 401
Partners in crime in the setting of recurring cardiac arrest 400
Next generation sequencing and linkage analysis for the molecular diagnosis of a novel overlapping syndrome characterized by hypertrophic cardiomyopathy and typical electrical instability of brugada syndrome 396
Coronary flow: a new asset for the echo lab? 395
Totale 46.768
Categoria #
all - tutte 134.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.142


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.066 0 0 0 0 67 133 76 91 105 106 107 381
2022/20232.291 202 212 56 335 216 451 170 229 189 22 149 60
2023/2024772 98 33 62 16 86 193 52 54 14 31 11 122
2024/20253.592 127 712 347 207 123 236 271 199 326 407 343 294
2025/20266.189 569 281 621 626 634 239 862 653 621 505 241 337
2026/20272.424 286 290 1.022 801 25 0 0 0 0 0 0 0
Totale 57.285